Related Experiment Video
Updated: Aug 11, 2025

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
The predictive value of the systemic immune-inflammatory index for left atrial appendage thrombus in non-valvular
Fatih Koca1, Fatih Levent1, Baris Sensoy1
1Bursa Education and Research Hospital, University of Health Sciences, Bursa, Turkey.
Insights
The systemic immune inflammatory index (SII) can predict left atrial appendage (LAA) thrombus in non-valvular atrial fibrillation patients. This accessible test aids in determining anticoagulant therapy decisions.
Area of Science:
- Cardiology
- Hematology
- Inflammation Research
Background:
- The systemic immune inflammatory index (SII) is recognized for its prognostic capabilities in cardiovascular diseases.
- Non-valvular atrial fibrillation (NVAF) poses a significant risk for thromboembolic events, particularly left atrial appendage (LAA) thrombus formation.
Purpose of the Study:
- To evaluate the predictive value of the SII for the presence of LAA thrombus in patients diagnosed with NVAF.
- To determine if SII can serve as a biomarker for guiding anticoagulant treatment decisions in this patient cohort.
Main Methods:
- A cohort of 525 patients with newly diagnosed NVAF, treatment-naïve for anticoagulation, were included.
- Transesophageal echocardiography was performed on all participants to assess for LAA thrombus.
- Multivariate regression analysis and ROC curve analysis were employed to identify predictors of LAA thrombus.
Main Results:
- Left atrial appendage thrombus was identified in 16.4% of the study population.
- The SII demonstrated significant diagnostic power for LAA thrombus (AUC: 0.760, P<0.001).
- Independent predictors for LAA thrombus included diabetes, LAA emptying rate <20 cm/s, and an SII value >750 (all P<0.05).
Conclusions:
- The SII is a practical and readily available marker that effectively predicts LAA thrombus in patients with NVAF.
- The findings suggest that SII can be a valuable tool in clinical decision-making regarding anticoagulant therapy for NVAF patients.
Objective:
The systemic immune inflammatory index (SII) has prognostic value in cardiovascular diseases. The aim of current study was to investigate whether or not left atrial appendage (LAA) thrombus could be predicted by SII in patients with non-valvular atrial fibrillation.
Method:
The study included 525 patients newly diagnosed with non-valvular atrial fibrillation, who had not previously had anticoagulant treatment (50.7% male, mean age 62.94±10.79 years). All patients underwent transoesophageal echocardiography.
Results:
LAA thrombus was observed in 86 patients (16.4%). In the ROC curve SII had a good diagnostic power in predicting LAA thrombus (AUC: 0.760, 95% CI: 0.703-0.818, P<0.001). In the multivariate regression analysis, diabetes (Hazard ratio: 2.264, 95% CI: 1.169-4.389, P=0.015), LAA emptying rate of <20 cm/s (Hazard ratio: 59.347, 95% CI: 25.397-138.680, P<0.001), and SII value of >750 (Hazard ratio: 4.291, 95% CI: 2.144-8.586 P<0.001) were determined as independent predictors for LAA thrombus. A poor correlation was found between SII and the CHADS2 VASc score (r=0.239, P<0.001) Conclusion. The SII, a practical and easily obtained test, can be used as a predictor of LAA thrombus in patients with non-valvular atrial fibrillation, and to decide on the anticoagulant treatment.
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Assessment of the Cardiovascular System III: Palpation
Jugular Venous Pressure (JVP) Measurement
Position the patient at a thirty- to forty-five-degree angle or in a semi-fowler's position. Look for the highest point of pulsation in the internal jugular vein and measure the vertical distance to the angle of Loius or sternal angle. A normal JVP is 3-4 cm above...

